Depression can make time feel narrow. You may have taken medication consistently, attended therapy, adjusted your routines, and still found that the heaviness remained. When this happens, the phrase treatment-resistant depression may enter the conversation.
It is an important term, but it should not become a verdict. It does not mean you have failed treatment, or that nothing can help. It describes a clinical pattern that deserves a closer look, including at what you have tried, how each treatment was used, and what may be complicating recovery.
When depression persists despite treatment
Treatment-resistant depression, often shortened to TRD, generally refers to depression that has not improved adequately after two appropriate antidepressant medication trials. “Appropriate” matters. A medication trial should involve a sufficient dose, enough time to assess its effect, and consistent use whenever possible.
Still, the definition is not perfectly uniform. Depression is not a single, identical experience from one person to another, and treatment history is rarely simple. A missed dose during a difficult month is different from a carefully completed medication trial. Side effects that made a medication impossible to continue are clinically meaningful too.
TRD is also not rare. A large US analysis found that treatment-resistant depression carries substantial personal and health-care burden, particularly when symptoms continue over time across people living with treatment-resistant depression (Zhdanava et al., 2021). That reality is one reason we believe an evaluation should be careful rather than rushed.
What counts as a prior treatment trial
We begin by listening to the full story, not simply counting prescriptions. Your history may include antidepressants, psychotherapy, changes in sleep or substance use, hospital care, or periods when depression improved and then returned.
A useful treatment history often includes:
The names of medications you have tried, along with dose and duration
Whether you took them consistently and what made consistency difficult
Benefits you noticed, even if they were partial or short-lived
Side effects, including emotional blunting, agitation, sleep changes, or sexual side effects
Therapy approaches you have tried and whether they felt like a good fit
Previous episodes of depression, their severity, and what helped in the past
Family history of depression, bipolar disorder, substance use, or suicide
A medication that caused intolerable side effects is not a meaningless attempt. Nor is a medication that helped somewhat but left you unable to function fully. These details shape what comes next.
For older adults, medical conditions, medication interactions, cognitive changes, and the particular risks of certain treatments can add further layers to the assessment. Clinical discussion of later-life treatment-resistant depression emphasizes the need to consider these overlapping factors rather than treating persistent symptoms as a medication problem alone (Steffens, 2024).
Looking beyond the depression diagnosis
Sometimes persistent depression reflects an incomplete diagnosis. Sometimes it reflects more than one condition occurring at once. We consider whether anxiety, trauma symptoms, alcohol or substance use, chronic pain, grief, or major life stress may be keeping the nervous system under strain.
We also ask about periods of unusually elevated energy, less need for sleep, impulsivity, racing thoughts, or a mood that felt markedly different from your usual self. Those experiences may warrant a closer look at bipolar-spectrum symptoms. This distinction matters because the treatment plan for depression may need to change when bipolar disorder is part of the picture. You can learn more about our approach to bipolar disorder treatment.
Physical health belongs in the conversation as well. Thyroid concerns, sleep disorders, anemia, chronic pain, hormonal changes, nutritional issues, and medication effects can all influence mood, energy, concentration, and motivation. A thorough evaluation may include coordination with your primary care clinician or other specialists when needed.
Why symptom severity and safety matter
We ask direct questions about daily functioning. Can you get out of bed? Are you eating and sleeping? Can you work, care for children, return calls, or experience moments of connection? Depression severity is not measured by one score alone. It is also measured in the parts of life that have become hard to reach.
We also ask about thoughts of death, self-harm, or suicide. These questions are not an accusation. They are part of responsible care. If you are in immediate danger, call 911 or go to the nearest emergency department. If you are having thoughts of suicide or need immediate support, contact the 988 Suicide and Crisis Lifeline (988 Suicide and Crisis Lifeline, n.d.) by calling or texting 988.
Treatment options may change after a careful review
An evaluation can identify practical next steps. That may mean optimizing a current medication, changing medications, adding psychotherapy, addressing sleep or substance use, seeking medical evaluation, or considering an intervention that works differently from standard oral antidepressants.
For some adults with depression, IV infusion treatment may become part of an individualized plan. Ketamine used for psychiatric purposes is off-label, meaning it is not FDA-approved for depression, and it is not appropriate for everyone. We review medical history, psychiatric history, current medications, safety considerations, and treatment goals before deciding whether it should be considered.
Research has examined repeated ketamine infusions in people with treatment-resistant depression, including questions about initial and maintenance dosing in a randomized trial of infusion schedules (Phillips et al., 2019). A systematic review of real-world studies also found potential benefit while underscoring variation in protocols, follow-up, and individual response across real-world ketamine studies (Alnefeesi et al., 2022). Those findings are useful, but they do not predict what any one person will experience.
If ketamine is being considered, we discuss the practical experience as openly as the clinical questions. Our ketamine infusion protocol explains how treatment series are structured, while our guide to the patient experience addresses what an infusion visit can feel like.
The value of an individualized plan
A treatment-resistant depression evaluation is not a search for the one missing answer. It is a way of organizing what has happened, clarifying what remains uncertain, and choosing a next step with greater intention.
We may find that prior treatment was incomplete because of side effects, access barriers, or an inadequate dose or duration. We may identify a co-occurring condition that needs attention. We may also confirm that you have tried thoughtful, adequate care and now need a different level or type of support.
Other interventions for treatment-resistant depression continue to be studied. For example, intranasal esketamine has been evaluated alongside oral antidepressant therapy in adults with TRD in a randomized clinical trial (Daly et al., 2018). The larger point is not that every option fits every person. It is that persistent depression deserves more than repetition of the same plan.
FAQ
Does treatment-resistant depression mean medication will never work?
No. It means prior treatment has not provided adequate relief. Sometimes a different medication strategy helps. Sometimes the clearest next step is psychotherapy, medical care, an intervention, or a combination of approaches. We avoid assuming that one disappointing experience predicts every future one.
Do I need to have tried exactly two medications?
Two adequate antidepressant trials are a common clinical benchmark, but the evaluation is more nuanced than a number. Medication duration, dose, side effects, adherence, symptom pattern, and your broader history all matter.
Should I bring records to an evaluation?
If you have medication lists, prior psychiatric records, therapy notes, or lab results, they can be helpful. But do not delay reaching out because you cannot find everything. We can begin with what you remember and build the history from there.
Is ketamine automatically the next step?
No. Ketamine is one possible consideration for depression, not an automatic answer. We make recommendations based on your symptoms, history, medical factors, safety needs, and preferences. You can also review common questions in our ketamine FAQs.
When it is time to take a closer look
You do not need to prove that you have struggled enough before asking for a more complete evaluation. If depression has remained present through treatment, it is reasonable to pause and look carefully at the whole picture.
At Southern Mind & Wellness, we approach that conversation with attention to the details that often get lost in a short appointment. If you are ready to discuss your treatment history and possible next steps in Vestavia Hills, call us at 205-557-2253.
Works Cited
1. Steffens DC. Treatment-Resistant Depression in Older Adults. https://pubmed.ncbi.nlm.nih.gov/38354142/
2. Alnefeesi Y, et al. Real-world effectiveness of ketamine in treatment-resistant depression: A systematic review & meta-analysis. https://pubmed.ncbi.nlm.nih.gov/35688035/
3. Daly EJ, et al. Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial. https://pubmed.ncbi.nlm.nih.gov/29282469/
4. Zhdanava M, et al. The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States. https://pubmed.ncbi.nlm.nih.gov/33989464/
5. Phillips JL, et al. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. https://pubmed.ncbi.nlm.nih.gov/30922101/
6. 988 Suicide and Crisis Lifeline. https://988lifeline.org/
Disclaimer
This article is for educational purposes only and is not a substitute for individualized evaluation, diagnosis, or treatment from a qualified healthcare professional.